chartexchange

Dogwood Therapeutics Announces Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 5, 2026 8:30 AM EST

- Completed the Halneuron ® Phase 2b trial in Chemotherapy Induced Neuropathy, top-line results to be announced in November 2026 -

Read original article